_id
6915f808bc934aba376b2540
Ticker
SHIEF
Name
Shield Therapeutics plc
Exchange
OTCQB
Address
Northern Design Centre, Gateshead, United Kingdom, NE8 3DF
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://www.shieldtherapeutics.com
Description
Shield Therapeutics plc, a commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs. Its lead product is Accrufer/Feraccru, a non-salt based oral therapy for adults to treat the iron deficiency with or without anemia. Shield Therapeutics plc was incorporated in 2008 and is based in Gateshead, the United Kingdom.
Last Close
0.146
Volume
-
Current Price
0.1474
Change
0
Last Updated
2026-01-07T11:42:14.112Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
155902912
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2023-06-30
Revenue
-
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
-
Operating Income
-
Interest Expense
-
Pretax Income
-
Net Income
-
Eps
-
Dividends Per Share
-
Shares Outstanding
1067828251
Income Tax Expense
406000
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-
Cash
13594000
Short Term Investments
-
Receivables
9812000
Inventories
2695000
Total Current Assets
26101000
Property Plant Equipment
327000
Total Assets
41667000
Payables
8080000
Short Term Debt
-
Long Term Debt
5705000
Total Liabilities
14565000
Equity
27102000
Bs_currency_symbol
USD
Depreciation
68000
Change In Working Capital
-
Cash From Operations
-9948000
Capital Expenditures
89000
Cash From Investing
-659000
Cash From Financing
15065000
Net Change In Cash
5096000
Cf_currency_symbol
USD
PE
-
PB
3.878000029916611
ROE
-
ROA
-
FCF
-10037000
Fcf Percent
-
Piotroski FScore
0
Health Score
51
Deep Value Investing Score
2.5
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
2
Garp Investing Score
1
Growth Investing Score
0
Momentum Investing Score
2
Net Net Investing Score
2.5
Quality Investing Score
1.5
Value Investing Score
4
Quarters > 0 > quarter
2023-06-30
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
-
Quarters > 0 > income Statement > operating Income
-
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-
Quarters > 0 > income Statement > net Income
-
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
713036342
Quarters > 0 > income Statement > income Tax Expense
406000
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
13594000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
9812000
Quarters > 0 > balance Sheet > inventories
2695000
Quarters > 0 > balance Sheet > total Current Assets
26101000
Quarters > 0 > balance Sheet > property Plant Equipment
327000
Quarters > 0 > balance Sheet > total Assets
41667000
Quarters > 0 > balance Sheet > payables
8080000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
5705000
Quarters > 0 > balance Sheet > total Liabilities
14565000
Quarters > 0 > balance Sheet > equity
27102000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-6302500
Quarters > 0 > cash Flow > depreciation
68000
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-9948000
Quarters > 0 > cash Flow > capital Expenditures
89000
Quarters > 0 > cash Flow > cash From Investing
-659000
Quarters > 0 > cash Flow > cash From Financing
15065000
Quarters > 0 > cash Flow > net Change In Cash
5096000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
3.878000029916611
Quarters > 0 > ratios > ROE
-
Quarters > 0 > ratios > ROA
-
Quarters > 0 > ratios > FCF
-10037000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
51
Quarters > 1 > quarter
2023-03-31
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
-
Quarters > 1 > income Statement > operating Income
-
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-
Quarters > 1 > income Statement > net Income
-
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
-
Quarters > 1 > income Statement > income Tax Expense
406000
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
-
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
9812000
Quarters > 1 > balance Sheet > inventories
2695000
Quarters > 1 > balance Sheet > total Current Assets
26101000
Quarters > 1 > balance Sheet > property Plant Equipment
327000
Quarters > 1 > balance Sheet > total Assets
-
Quarters > 1 > balance Sheet > payables
8080000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
8860000
Quarters > 1 > balance Sheet > equity
-
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-6302500
Quarters > 1 > cash Flow > depreciation
68000
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-9948000
Quarters > 1 > cash Flow > capital Expenditures
89000
Quarters > 1 > cash Flow > cash From Investing
-659000
Quarters > 1 > cash Flow > cash From Financing
15065000
Quarters > 1 > cash Flow > net Change In Cash
5096000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
-
Quarters > 1 > ratios > ROA
-
Quarters > 1 > ratios > FCF
-10037000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
45
Quarters > 2 > quarter
2022-12-31
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
-
Quarters > 2 > income Statement > operating Income
-
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-
Quarters > 2 > income Statement > net Income
-
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
267016758
Quarters > 2 > income Statement > income Tax Expense
4000
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
2821000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
5816000
Quarters > 2 > balance Sheet > inventories
1457000
Quarters > 2 > balance Sheet > total Current Assets
10094000
Quarters > 2 > balance Sheet > property Plant Equipment
197000
Quarters > 2 > balance Sheet > total Assets
22074000
Quarters > 2 > balance Sheet > payables
9489000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
6008000
Quarters > 2 > balance Sheet > total Liabilities
16647000
Quarters > 2 > balance Sheet > equity
5427000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-14331000
Quarters > 2 > cash Flow > depreciation
780000
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-4742000
Quarters > 2 > cash Flow > capital Expenditures
9000
Quarters > 2 > cash Flow > cash From Investing
-313500
Quarters > 2 > cash Flow > cash From Financing
3825000
Quarters > 2 > cash Flow > net Change In Cash
208500
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
7.252307007407407
Quarters > 2 > ratios > ROE
-
Quarters > 2 > ratios > ROA
-
Quarters > 2 > ratios > FCF
-4751000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2022-09-30
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
-
Quarters > 3 > income Statement > operating Income
-
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-
Quarters > 3 > income Statement > net Income
-
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
-
Quarters > 3 > income Statement > income Tax Expense
4000
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
-
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
5816000
Quarters > 3 > balance Sheet > inventories
1457000
Quarters > 3 > balance Sheet > total Current Assets
10094000
Quarters > 3 > balance Sheet > property Plant Equipment
197000
Quarters > 3 > balance Sheet > total Assets
-
Quarters > 3 > balance Sheet > payables
9489000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
10639000
Quarters > 3 > balance Sheet > equity
-
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-14331000
Quarters > 3 > cash Flow > depreciation
780000
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-4742000
Quarters > 3 > cash Flow > capital Expenditures
9000
Quarters > 3 > cash Flow > cash From Investing
-313500
Quarters > 3 > cash Flow > cash From Financing
3825000
Quarters > 3 > cash Flow > net Change In Cash
208500
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
-
Quarters > 3 > ratios > ROA
-
Quarters > 3 > ratios > FCF
-4751000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
45
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
32180000
Annuals > 0 > income Statement > cost Of Revenue
17250000
Annuals > 0 > income Statement > gross Profit
14930000
Annuals > 0 > income Statement > operating Expenses
55053000
Annuals > 0 > income Statement > operating Income
-22873000
Annuals > 0 > income Statement > interest Expense
3873000
Annuals > 0 > income Statement > pretax Income
-26556000
Annuals > 0 > income Statement > net Income
-27182000
Annuals > 0 > income Statement > eps
-0.026094123367263092
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
1041690484
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-71.0783095090118
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
6524000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
12275000
Annuals > 0 > balance Sheet > inventories
5661000
Annuals > 0 > balance Sheet > total Current Assets
37939000
Annuals > 0 > balance Sheet > property Plant Equipment
373000
Annuals > 0 > balance Sheet > total Assets
57480000
Annuals > 0 > balance Sheet > payables
6518000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
26174000
Annuals > 0 > balance Sheet > total Liabilities
58797000
Annuals > 0 > balance Sheet > equity
-1317000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-27182000
Annuals > 0 > cash Flow > depreciation
1425000
Annuals > 0 > cash Flow > change In Working Capital
14580000
Annuals > 0 > cash Flow > cash From Operations
-6770000
Annuals > 0 > cash Flow > capital Expenditures
2421000
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-
Annuals > 0 > cash Flow > net Change In Cash
-7498000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.026094123367263092
Annuals > 0 > ratios > PB
-115.4797347486712
Annuals > 0 > ratios > ROE
2063.933181473045
Annuals > 0 > ratios > ROA
-47.28949199721642
Annuals > 0 > ratios > FCF
-9191000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-0.2856121814791796
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
13085000
Annuals > 1 > income Statement > cost Of Revenue
9058000
Annuals > 1 > income Statement > gross Profit
4027000
Annuals > 1 > income Statement > operating Expenses
44416000
Annuals > 1 > income Statement > operating Income
-31331000
Annuals > 1 > income Statement > interest Expense
1016000
Annuals > 1 > income Statement > pretax Income
-32375000
Annuals > 1 > income Statement > net Income
-33293000
Annuals > 1 > income Statement > eps
-0.04257110024909496
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
782056367
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-239.44210928544135
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
13948000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
9988000
Annuals > 1 > balance Sheet > inventories
3203000
Annuals > 1 > balance Sheet > total Current Assets
31263000
Annuals > 1 > balance Sheet > property Plant Equipment
673000
Annuals > 1 > balance Sheet > total Assets
48799000
Annuals > 1 > balance Sheet > payables
4049000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
19836000
Annuals > 1 > balance Sheet > total Liabilities
33766000
Annuals > 1 > balance Sheet > equity
15033000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-26604100
Annuals > 1 > cash Flow > depreciation
1071000
Annuals > 1 > cash Flow > change In Working Capital
-7024000
Annuals > 1 > cash Flow > cash From Operations
-37126000
Annuals > 1 > cash Flow > capital Expenditures
2948000
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-
Annuals > 1 > cash Flow > net Change In Cash
10100000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.04257110024909496
Annuals > 1 > ratios > PB
7.595305633073904
Annuals > 1 > ratios > ROE
-221.46610789596218
Annuals > 1 > ratios > ROA
-68.2247587040718
Annuals > 1 > ratios > FCF
-40074000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-3.0625907527703475
Annuals > 1 > health Score
13
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
4467000
Annuals > 2 > income Statement > cost Of Revenue
2470000
Annuals > 2 > income Statement > gross Profit
1997000
Annuals > 2 > income Statement > operating Expenses
30173000
Annuals > 2 > income Statement > operating Income
-25706000
Annuals > 2 > income Statement > interest Expense
389000
Annuals > 2 > income Statement > pretax Income
-40082000
Annuals > 2 > income Statement > net Income
-40444000
Annuals > 2 > income Statement > eps
-0.15592085987015591
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
259388000
Annuals > 2 > income Statement > income Tax Expense
362000
Annuals > 2 > income Statement > EBITDA
-37331000
Annuals > 2 > income Statement > operating Margin
-575.4645175733154
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
2821000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
3388000
Annuals > 2 > balance Sheet > inventories
1457000
Annuals > 2 > balance Sheet > total Current Assets
10094000
Annuals > 2 > balance Sheet > property Plant Equipment
197000
Annuals > 2 > balance Sheet > total Assets
22074000
Annuals > 2 > balance Sheet > payables
9489000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
6008000
Annuals > 2 > balance Sheet > total Liabilities
16647000
Annuals > 2 > balance Sheet > equity
5427000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-40444000
Annuals > 2 > cash Flow > depreciation
2362000
Annuals > 2 > cash Flow > change In Working Capital
4708000
Annuals > 2 > cash Flow > cash From Operations
-18247000
Annuals > 2 > cash Flow > capital Expenditures
53000
Annuals > 2 > cash Flow > cash From Investing
-1695000
Annuals > 2 > cash Flow > cash From Financing
7707000
Annuals > 2 > cash Flow > net Change In Cash
-9296000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.15592085987015591
Annuals > 2 > ratios > PB
6.978192002948221
Annuals > 2 > ratios > ROE
-745.2367790676249
Annuals > 2 > ratios > ROA
-183.22007791972456
Annuals > 2 > ratios > FCF
-18300000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-4.09670920080591
Annuals > 2 > health Score
8
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
1519000
Annuals > 3 > income Statement > cost Of Revenue
980000
Annuals > 3 > income Statement > gross Profit
539000
Annuals > 3 > income Statement > operating Expenses
21471000
Annuals > 3 > income Statement > operating Income
-19952000
Annuals > 3 > income Statement > interest Expense
8000
Annuals > 3 > income Statement > pretax Income
-19565000
Annuals > 3 > income Statement > net Income
-19336000
Annuals > 3 > income Statement > eps
-0.08957076813326292
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
215874000
Annuals > 3 > income Statement > income Tax Expense
-229000
Annuals > 3 > income Statement > EBITDA
-17350000
Annuals > 3 > income Statement > operating Margin
-1313.4957208689927
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
12117000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
3952000
Annuals > 3 > balance Sheet > inventories
1635000
Annuals > 3 > balance Sheet > total Current Assets
17258000
Annuals > 3 > balance Sheet > property Plant Equipment
304000
Annuals > 3 > balance Sheet > total Assets
44413000
Annuals > 3 > balance Sheet > payables
1311000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
0
Annuals > 3 > balance Sheet > total Liabilities
3380000
Annuals > 3 > balance Sheet > equity
41033000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-19336000
Annuals > 3 > cash Flow > depreciation
1619000
Annuals > 3 > cash Flow > change In Working Capital
-2007000
Annuals > 3 > cash Flow > cash From Operations
-16738000
Annuals > 3 > cash Flow > capital Expenditures
372000
Annuals > 3 > cash Flow > cash From Investing
-2051000
Annuals > 3 > cash Flow > cash From Financing
27584000
Annuals > 3 > cash Flow > net Change In Cash
9177000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.08957076813326292
Annuals > 3 > ratios > PB
0.7681038188774888
Annuals > 3 > ratios > ROE
-47.12304730338995
Annuals > 3 > ratios > ROA
-43.53680228761849
Annuals > 3 > ratios > FCF
-17110000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-11.263989466754444
Annuals > 3 > health Score
33
Valuation > metrics > PB
3.878000029916611
Valuation > final Score
41.21999970083389
Valuation > verdict
29.3% Overvalued
Profitability > final Score
50
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.5374142129732123
Risk > final Score
68
Risk > verdict
High
Liquidity > metrics > Current Ratio
3.2303217821782177
Liquidity > metrics > Quick Ratio
2.896782178217822
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
20
Prev Valuations > 2
50
Prev Profitabilities > 0
50
Prev Profitabilities > 1
50
Prev Profitabilities > 2
50
Prev Risks > 0
50
Prev Risks > 1
26
Prev Risks > 2
50
Prev Liquidities > 0
100
Prev Liquidities > 1
72
Prev Liquidities > 2
72
Updated At
2026-01-20T22:33:44.073Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-04-22
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2021-03-31
Earnings History > 1 > report Date
2021-06-30
Earnings History > 1 > date
2021-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-0.0275
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.0275
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2020-12-31
Earnings History > 2 > report Date
2021-03-31
Earnings History > 2 > date
2020-12-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.0274
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.0274
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2020-09-30
Earnings History > 3 > report Date
2020-12-31
Earnings History > 3 > date
2020-09-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.0302
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-0.0302
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2020-06-30
Earnings History > 4 > report Date
2020-09-30
Earnings History > 4 > date
2020-06-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.0285
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.0285
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2020-03-31
Earnings History > 5 > report Date
2020-06-30
Earnings History > 5 > date
2020-03-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
0.0165
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
0.0165
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2019-12-31
Earnings History > 6 > report Date
2020-03-31
Earnings History > 6 > date
2019-12-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
0.0166
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
0.0166
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2019-09-30
Earnings History > 7 > report Date
2019-12-31
Earnings History > 7 > date
2019-09-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.0261
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
-0.0261
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2019-06-30
Earnings History > 8 > report Date
2019-09-30
Earnings History > 8 > date
2019-06-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.0242
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.0242
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2019-03-31
Earnings History > 9 > report Date
2019-06-30
Earnings History > 9 > date
2019-03-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.0227
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.0227
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2018-12-31
Earnings History > 10 > report Date
2019-03-31
Earnings History > 10 > date
2018-12-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.0233
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.0233
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2018-09-30
Earnings History > 11 > report Date
2018-12-31
Earnings History > 11 > date
2018-09-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
0.0342
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
0.0342
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-06-30
Earnings History > 12 > report Date
2018-09-30
Earnings History > 12 > date
2018-06-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
0.035
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
0.035
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2018-03-31
Earnings History > 13 > report Date
2018-06-30
Earnings History > 13 > date
2018-03-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.0456
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.0456
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2017-12-31
Earnings History > 14 > report Date
2018-03-31
Earnings History > 14 > date
2017-12-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.0485
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.0485
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2017-09-30
Earnings History > 15 > report Date
2017-12-31
Earnings History > 15 > date
2017-09-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.0577
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.0577
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2017-06-30
Earnings History > 16 > report Date
2017-09-30
Earnings History > 16 > date
2017-06-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.0573
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.0573
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2017-03-31
Earnings History > 17 > report Date
2017-06-30
Earnings History > 17 > date
2017-03-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.0579
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-0.0579
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2016-12-31
Earnings History > 18 > report Date
2017-03-31
Earnings History > 18 > date
2016-12-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.0557
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.0557
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2016-09-30
Earnings History > 19 > report Date
2016-12-31
Earnings History > 19 > date
2016-09-30
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.0365
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.0365
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2016-06-30
Earnings History > 20 > report Date
2016-09-30
Earnings History > 20 > date
2016-06-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.0384
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.0384
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2016-03-31
Earnings History > 21 > report Date
2016-06-30
Earnings History > 21 > date
2016-03-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.0598
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.0598
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2015-12-31
Earnings History > 22 > report Date
2016-03-31
Earnings History > 22 > date
2015-12-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.0648
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-0.0648
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2015-09-30
Earnings History > 23 > report Date
2015-12-31
Earnings History > 23 > date
2015-09-30
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
0.0862
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
0.0862
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2015-06-30
Earnings History > 24 > report Date
2015-09-30
Earnings History > 24 > date
2015-06-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
0.0885
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
0.0885
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2015-03-31
Earnings History > 25 > report Date
2015-06-30
Earnings History > 25 > date
2015-03-31
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.7312
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
-0.7312
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2014-12-31
Earnings History > 26 > report Date
2015-03-31
Earnings History > 26 > date
2014-12-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.6908
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
-0.6908
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2014-09-30
Earnings History > 27 > report Date
2014-12-31
Earnings History > 27 > date
2014-09-30
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.0814
Earnings History > 27 > eps Estimate
0
Earnings History > 27 > eps Difference
-0.0814
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2014-06-30
Earnings History > 28 > report Date
2014-09-30
Earnings History > 28 > date
2014-06-30
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.0847
Earnings History > 28 > eps Estimate
0
Earnings History > 28 > eps Difference
-0.0847
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2014-03-31
Earnings History > 29 > report Date
2014-06-30
Earnings History > 29 > date
2014-03-31
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-0.1947
Earnings History > 29 > eps Estimate
0
Earnings History > 29 > eps Difference
-0.1947
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2013-12-31
Earnings History > 30 > report Date
2014-03-31
Earnings History > 30 > date
2013-12-31
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-0.1898
Earnings History > 30 > eps Estimate
0
Earnings History > 30 > eps Difference
-0.1898
Earnings History > 30 > surprise Percent
-
Shield Therapeutics plc, a commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs. Its lead product is Accrufer/Feraccru, a non-salt based oral therapy for adults to treat the iron deficiency with or without anemia. Shield Therapeutics plc was incorporated in 2008 and is based in Gateshead, the United Kingdom.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ANSE IPO: SEBI Chief hints at NOC this month; unlisted shares surge past Rs 2,000—Is the issue likely soon? The Financial Express
Read more →NSE to get no-objection certificate for IPO by month-end, says Sebi chief Mint
Read more →Showing 2 of 10
(Last Updated 2023-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Debt to Equity
-
High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Shield Therapeutics plc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2026-03-31
EPS Estimate
—
Date
2021-03-31
EPS Actual
-0.0275
EPS Estimate
0
EPS Difference
-0.0275
Surprise Percent
0%
(Last Updated 2023-06-30)
(Last Updated 2023-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2023-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2023-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.